Radiofluorinated Analogs of NCS-382 as Potential PET Tracers for Imaging the CaMKIIα Hub Domain
ACS Chemical Neuroscience · 2025
DOI: 10.1021/acschemneuro.4c00778 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2025. Verfasst von Ludovica S Sirocchi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, Copenhagen 2100, …. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Calcium-Calmodulin-Dependent Protein Kinase Type 2, Brain, Radiopharmaceuticals. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Simon Fougner Hartmanns Familiefond, Danmarks Frie Forskningsfond, Novo Nordisk Fonden.
Abstract (Originalsprache)
The Ca2+/calmodulin-dependent protein kinase II alpha (CaMKIIα) is a key regulator of calcium signaling in the central nervous system and is suggested to play a crucial role in neurodegenerative diseases and stroke. The CaMKIIα hub domain was recently identified as a high-affinity binding site for γ-hydroxybutyric acid (GHB), representing a new target for neurological research and therapy. In this study, we synthesized and evaluated two novel radiofluorinated GHB analogs, [18F]6 and [18F]9, to visualize CaMKIIα via this domain in vivo using positron emission tomography (PET). In vitro autoradiography demonstrated specific binding of [18F]6 to CaMKIIα-rich brain regions, whereas [18F]9 exhibited apparent nonspecific myelin binding. In vivo, [18F]6 crossed the blood-brain barrier but did not exhibit effective PET imaging of CaMKIIα presumably due to a too low affinity. Despite this limitation, the brain penetrance of the compound suggests that further chemical modifications could enhance its suitability for neuroimaging. This work provides a foundation for future radiotracer development targeting CaMKIIα.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, Copenhagen 2100, Denmark.
- Department of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital-Rigshospitalet, Blegdamsvej 9, Copenhagen 2100, Denmark.
ORCID-Profile: Ludovica S Sirocchi, Sophie Stotz, Marius Müller, Vladimir Shalgunov, Petrine Wellendorph, Bente Fro̷lund, Matthias M Herth
Förderung
- Simon Fougner Hartmanns Familiefond
- Danmarks Frie Forskningsfond
- Novo Nordisk Fonden
- H2020 Marie Sklodowska-Curie Actions
Zitieren
APA
Sirocchi, L. S., Stotz, S., Müller, M., Pedersen, N. B., Thiesen, L., Mattiussi, S., Avgerinos, C., Shalgunov, V., Wellendorph, P., Fro̷lund, B., & Herth, M. M. (2025). Radiofluorinated Analogs of NCS-382 as Potential PET Tracers for Imaging the CaMKIIα Hub Domain. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.4c00778
Vancouver
Sirocchi LS, Stotz S, Müller M, Pedersen NB, Thiesen L, Mattiussi S, et al. Radiofluorinated Analogs of NCS-382 as Potential PET Tracers for Imaging the CaMKIIα Hub Domain. ACS Chemical Neuroscience. 2025. doi:10.1021/acschemneuro.4c00778
BibTeX
@article{Sirocchi2025,
author = {Sirocchi, Ludovica S and Stotz, Sophie and Müller, Marius and Pedersen, Nadia Billesborg and Thiesen, Louise and Mattiussi, Simona and Avgerinos, Christos and Shalgunov, Vladimir and Wellendorph, Petrine and Fro̷lund, Bente and Herth, Matthias M},
title = {Radiofluorinated Analogs of NCS-382 as Potential PET Tracers for Imaging the CaMKIIα Hub Domain},
journal = {ACS Chemical Neuroscience},
year = {2025},
doi = {10.1021/acschemneuro.4c00778}
}
EUVIMED